CSat Investment Advisory’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,351
Closed -$131K 1091
2019
Q3
$131K Buy
1,351
+246
+22% +$24.6K 0.04% 276
2019
Q2
$113K Buy
+1,105
New +$119K 0.04% 282

CSat Investment Advisory's ONCE Position: Q4 2019 in Review

CSat Investment Advisory sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,351 shares — an estimated $131K sold.

CSat Investment Advisory first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $131K in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • CSat Investment Advisory reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • CSat Investment Advisory sold 1,351 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $131K.
  • CSat Investment Advisory first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • CSat Investment Advisory's Spark Therapeutics, Inc. Common Stock position peaked at $131K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on CSat Investment Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.